ইউরোপীয় ইউনিয়ন -
ইংরেজি -
EMA (European Medicines Agency)
ongentys
bial - portela cª, s.a. - opicapone - parkinson disease - anti-parkinson drugs - ongentys is indicated as adjunctive therapy to preparations of levodopa/ dopa decarboxylase inhibitors (ddci) in adult patients with parkinson’s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.ongentys is indicated as adjunctive therapy to preparations of levodopa/ dopa decarboxylase inhibitors (ddci) in adult patients with parkinson’s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.
যুক্তরাজ্য -
ইংরেজি -
MHRA (Medicines & Healthcare Products Regulatory Agency)
comtess 200mg tablets
orion pharma (uk - entacapone - tablet - 200mg
যুক্তরাজ্য -
ইংরেজি -
MHRA (Medicines & Healthcare Products Regulatory Agency)
entacapone 200mg tablets
wockhardt uk ltd - entacapone - tablet - 200mg
যুক্তরাজ্য -
ইংরেজি -
MHRA (Medicines & Healthcare Products Regulatory Agency)
ongentys 50mg capsules
bial pharma uk ltd - opicapone - capsule - 50mg
মাল্টা -
ইংরেজি -
Medicines Authority
entacapone 200mg film-coated tablets
pinewood laboratories limited ballymacarbry, clonmel, co. tipperary, ireland - entacapone - film-coated tablet - entacapone 200 mg - anti-parkinson drugs
মাল্টা -
ইংরেজি -
Medicines Authority
medapia 200mg film-coated tablets
medochemie limited 1-10 constantinoupleos street, 3011 limassol, cyprus - entacapone - film-coated tablet - entacapone 200 mg - anti-parkinson drugs
ইউরোপীয় ইউনিয়ন -
ইংরেজি -
EMA (European Medicines Agency)
ontilyv
bial portela & companhia s.a. - opicapone - parkinson disease - anti-parkinson drugs - ontilyv is indicated as adjunctive therapy to preparations of levodopa/ dopa decarboxylase inhibitors (ddci) in adult patients with parkinson’s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.
ইস্রায়েল -
ইংরেজি -
Ministry of Health
ongentys 50 mg
truemed ltd, israel - opicapone - hard capsule - opicapone 50 mg - opicapone - ongentys is indicated as adjunctive therapy to preparations of levodopa/ dopa decarboxylase inhibitors (ddci) in adult patients with parkinson’s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.
আয়ার্লণ্ড -
ইংরেজি -
HPRA (Health Products Regulatory Authority)
rivotril 1 mg/ml concentrate for solution for inje
roche products ltd - clonazepam - concentrate for soln for inj - 1
নিউ জিলণ্ড -
ইংরেজি -
Medsafe (Medicines Safety Authority)
entapone
viatris limited - entacapone 200mg; - film coated tablet - 200 mg - active: entacapone 200mg excipient: hydrogenated vegetable oil hyprolose magnesium stearate mannitol microcrystalline cellulose opadry orange water - entacapone is indicated as an adjunct to standard preparations of levodopa/benserazide or levodopa/carbidopa for use in patients with parkinson's disease and end-of-dose motor fluctuations, who cannot be stabilized on those combinations.